Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy

被引：0
|
作者：
Shiyu Zhu
Beibei Liang
Yuxuan Zhou
Yinfei Chen
Jiayu Fu
Ling Qiu
Jianguo Lin
机构：
[1] Jiangsu Institute of Nuclear Medicine,NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine
[2] Nanjing Medical University,Department of Radiopharmaceuticals, School of Pharmacy
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2024年 / 51卷
关键词：
Programmed cell death ligand-1 (PD-L1); Immunotherapy; Positron emission tomography (PET); Peptide-based radiotracer; Ga; F;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：625 / 640
页数：15
相关论文
共 50 条
  • [1] Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy
    Zhu, Shiyu
    Liang, Beibei
    Zhou, Yuxuan
    Chen, Yinfei
    Fu, Jiayu
    Qiu, Ling
    Lin, Jianguo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 625 - 640
  • [2] Development of Novel Peptide-Based Radiotracers for Detecting FGL1 Expression in Tumors
    Xu, Yue
    Zhang, Jinyuan
    Pan, Donghui
    Yan, Junjie
    Chen, Chongyang
    Wang, Lizhen
    Wang, Xinyu
    Yang, Min
    Xu, Yuping
    MOLECULAR PHARMACEUTICS, 2025, 22 (03) : 1605 - 1614
  • [3] Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeutics
    Hongzhang Yang
    Xinying Zeng
    Jia Liu
    Xuejun Wen
    Huanhuan Liu
    Yuanyuan Liang
    Xueqi Wang
    Jianyang Fang
    Qinglin Zhang
    Jindian Li
    Xianzhong Zhang
    Zhide Guo
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1582 - 1592
  • [4] Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeutics
    Yang, Hongzhang
    Zeng, Xinying
    Liu, Jia
    Wen, Xuejun
    Liu, Huanhuan
    Liang, Yuanyuan
    Wang, Xueqi
    Fang, Jianyang
    Zhang, Qinglin
    Li, Jindian
    Zhang, Xianzhong
    Guo, Zhide
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (06) : 1582 - 1592
  • [5] Develop a peptide-based PET radiotracer for imaging PD-L1 expression in cancer
    Hu, Kuan
    Zhang, Ming-Rong
    Hanyu, Masayuki
    Xie, Lin
    Zhang, Yiding
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S46 - S47
  • [6] A 64Cu-labeled peptide-based PET radiotracers for imaging PD-L1 expression in preclinical tumor models
    Zhang, Siqi
    Hu, Kuan
    Zhang, Lulu
    Wang, Yanrong
    Wang, Xingkai
    Shen, Jieting
    Wang, Feng
    Zhang, Ming-Rong
    Wang, Rui
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [7] Peptide-Based 68Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer
    De Silva, Ravindra A.
    Kumar, Dhiraj
    Lisok, Ala
    Chatterjee, Samit
    Wharram, Bryan
    Rao, Kalagadda Venkateswara
    Mease, Ronnie
    Dannals, Robert F.
    Pomper, Martin G.
    Nimmagadda, Sridhar
    MOLECULAR PHARMACEUTICS, 2018, 15 (09) : 3946 - 3952
  • [8] A 68Ga-labeled linear peptide-based PET radiotracers for imaging PD-L1 status in tumors
    Hu, Kuan
    Zhang, Siqi
    Zhang, Lulu
    Wang, Xingkai
    Shen, Jieting
    Xie, Lin
    Zhang, Ming-Rong
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S153 - S153
  • [9] Peptide-based and small molecule PD-1 and PD-L1 pharmacological modulators in the treatment of cancer
    Islam, Mohammad Kaisarul
    Stanslas, Johnson
    PHARMACOLOGY & THERAPEUTICS, 2021, 227
  • [10] Peptide-based and small synthetic molecule inhibitors on PD-1/PD-L1 pathway: A new choice for immunotherapy?
    Chen, Tingkai
    Li, Qi
    Liu, Zongliang
    Chen, Yao
    Feng, Feng
    Sun, Haopeng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 161 : 378 - 398
12345